Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 5 Pain, Postoperative 2 Neoplasms 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Stomach Neoplasms 1 Papillomavirus Infections 1 Lymphoma 1 Leukemia 1 Infections 1 Hyperglycemia 1 Gastrostomy 1 Chronic Pain 1 Brain Neoplasms 1 Attention Deficit Disorder with Hyperactivity 1

Interventions

ziprasidone 1 tocilizumab 1 talquetamab 1 idecabtagene vicleucel 1 golimumab 1 gilteritinib 1 anifrolumab 1 Zolpidem 1 X-Rays 1 Wearable Electronic Devices 1 Watchful Waiting 1 Warfarin 1 Vital Signs 1 Vecuronium Bromide 1 Vancomycin 1 Tumor Necrosis Factor Inhibitors 1 Tranexamic Acid 1 Tobramycin 1 Spironolactone 1 Sevelamer 1 Rocuronium 1 Rituximab 1 Procalcitonin 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Oxycodone 1 Nifedipine 1 Nafcillin 1 Molindone 1 Methylprednisolone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Infections × Control Groups × Clear all

NCT06655506 2024-10-23

ERGO

National and Kapodistrian University of Athens

Infections, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡